EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

Pietro Scilipoti iD, Hans Garmo, Rolf Gedeborg iD, David Robinson iD, Pär Stattin, Marcus Westerberg iD

JNCI: Journal of the National Cancer Institute · 2025

DOI: 10.1093/jnci/djaf012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Pietro Scilipoti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatectomy, Prostate-Specific Antigen, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Swedish Research Council, The Swedish Cancer Society, Region Uppsala.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There has been a wide range in incidence of prostate-specific antigen (PSA) persistence and relapse after radical prostatectomy (RP) for prostate cancer (PCa). We aimed to describe incidence and prognostic implications of PSA persistence and relapse.

Methods

Register-based cohort study in Sweden of men diagnosed with PCa between 2007 and 2020 who underwent RP. Risks were estimated using competing risk cumulative incidence curves. Treatment after persistence or relapse and risk of PCa death and other causes were stratified according to persistence, European Association of Urology relapse risk groups, time to relapse, and life expectancy based on age and comorbidities.

Results

Among 10 700 men, the 10-year risk of PSA persistence or relapse after RP was 34% (95% confidence interval = 32% to 35%). Within 12 months of persistence/relapse, 75% of men with persistence, high-risk relapse, or early relapse (<2 years) received treatment. The 10-year risk of PCa death ranged from 12% for men with persistence to 2% in men with low-risk relapse, whereas death from other causes ranged from 11% to 16%. Risk of PCa death was 8.5% after early relapse (<2 years) and 1.4% after late relapse (>5 years).

Conclusions

This population-based study estimated that one-third of men would have PSA persistence or relapse within 10 years from RP. There was a wide range in risk of death from PCa according to cancer characteristics and time to relapse. Risk of death from other causes was substantial. These factors, along with life expectancy, should inform treatment decisions for men with persistence or relapse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProstatectomyProstate-Specific AntigenNeoplasm Recurrence, LocalHumansMaleAgedSwedenIncidenceMiddle AgedPrognosisRegistriesCohort Studies

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Division of Experimental Oncology/Unit of Urology, URI Institution, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Department of Urology, Ryhov Hospital, Jönköping, Sweden.

ORCID-Profile: Pietro Scilipoti, Rolf Gedeborg, David Robinson, Marcus Westerberg

Förderung

  • The Swedish Research Council
  • The Swedish Cancer Society
  • Region Uppsala

Zitieren

APA

Scilipoti, P., Garmo, H., Gedeborg, R., Robinson, D., Stattin, P., & Westerberg, M. (2025). Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf012

Vancouver

Scilipoti P, Garmo H, Gedeborg R, Robinson D, Stattin P, Westerberg M. Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djaf012

BibTeX
@article{Scilipoti2025,
  author = {Scilipoti, Pietro and Garmo, Hans and Gedeborg, Rolf and Robinson, David and Stattin, Pär and Westerberg, Marcus},
  title = {Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2025},
  doi = {10.1093/jnci/djaf012}
}
Kostenlos starten →